Skip to main content
Clinical Trials/NCT06961773
NCT06961773Enrolling By InvitationNot Applicable

Bone Metabolism in Exercising WOMEN: Influence of Low Energy Availability and Sex Hormone Fluctuations

Universidad Politecnica de Madrid1 site in 1 country22 target enrollmentStarted: December 5, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
22
Locations
1
Primary Endpoint
Concentrations of other biochemical biomarkers

Study Overview

Brief Summary

The main goal of this study is to examine how sex hormones and low energy availability affect the concentrations of bone remodelling markers at rest and after a running protocol. The research questions to be addressed are:

1: Does the ovarian hormone profile influence serum bone marker concentrations in women exercising resting and in response to to exercise?

  1. Are there differences in response to low energy availability in bone marker concentrations between eumenorrhoeic female athletes and oral contraceptive users?

3: Is the response of bone markers affected by different exercise stimuli: endurance or aerobic endurance?

4: Do bone markers return to baseline levels after 24 hours of high energy availability diet after 6 days of low energy availability?

Detailed Description

To achieve the aim of the study, there will be two experimental groups - e.g. eumenorrhoeic females and oral contraceptive users - who, after screening, will be randomly assigned to a low- or high-energy diet. After 6 days on this diet, the participant will undergo an intervallic running protocol and blood samples will be taken before and after the test. The following month the participant will do the other type of diet.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 30 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Be healthy and between 18 and 30 years old.
  • •Engage in endurance sports that involve running (such as athletics, running, triathlon, trail running, etc.) for 3 to 12 hours per week..
  • •Eumenorrheic females with regular menstruation at least 6 months prior to the study.
  • •Monophasic oral contraceptive users at least 6 months prior to the study.

Exclusion Criteria

  • •Amenorrheic females.
  • •Pregnant females.
  • •Affected by any disorder related to the hypothalamo-pituitary-ovarian axis.
  • •Having suffered a bone fracture in the year before the study.
  • •Taking any medication or supplements that affect bone metabolism.

Arms & Interventions

Eumhenorreic females

Experimental

Intervention: Low energy availability (Other)

Eumhenorreic females

Experimental

Intervention: High energy availability (Other)

Oral concetraceptive users

Experimental

Intervention: Low energy availability (Other)

Oral concetraceptive users

Experimental

Intervention: High energy availability (Other)

Outcomes

Primary Outcomes

Concentrations of other biochemical biomarkers

Time Frame: Immediately pre-exercise and immediately, 15 minutes and 24 hours post-exercise

Concentrations of Triiodothyronine (T3), Albumin, Sex Hormone Binding Globulin (SHBG), etc. measured in serum

Concentration of bone metabolism biomarkers

Time Frame: immediately pre-exercise and immediately, 15 minutes and 24 hours post-exercise

Concentration of procollagen type I N-propeptide (P1NP), cross-linking telopeptide of type I collagen (βCTX-1), paratyroid hormone, calcium, sclerostin, osteoprotegin, osteocalcin, bone alkaline phospatase, Receptor Activator for Nuclear Factor κ B Ligand (RANKL) measured in serum samples.

Concentrations of sex hormones

Time Frame: Immediately pre-exercise and immediately, 15 minutes and 24 hours post-exercise

Concentrations of 17β-Oestradiol and Progesterone measured in serum.

Bone mineral density

Time Frame: At the screening phase

Total, lumbar spine and femoral neck bone mineral density (g/cm\^2) measured by dual x-ray absorptiometry

Secondary Outcomes

  • Training status variables(At the screening phase)
  • Body composition variables(Immediately pre- and post-nutritional intervention (bioimpedance) and DXA at the screening)
  • Body metrics(Measured at the screening phase)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

ANA BELEN PEINADO LOZANO

Principal Investigator

Universidad Politecnica de Madrid

Study Sites (1)

Loading locations...

Similar Trials